Skip to main content
BusinessResearch

Demis Hassabis’ AI company raises $5 billion, months after he left as Google DeepMind CEO

Source: CNBC Tech (opens in a new tab)

Intel Summary

CNBC reports that Demis Hassabis' AI company, Isomorphic Labs, has raised $5 billion to develop new medicines using artificial intelligence. The capital raise follows Hassabis' departure as CEO of Google DeepMind months earlier.

Why It Matters

A $5 billion round represents one of the largest capital commitments dedicated to AI-driven pharmaceutical research. It underscores substantial investor conviction in computational drug design, though specific investor identities and valuation terms are not specified in the supplied material.

Organizations & Entities